ArriVent BioPharma Inc. C...

18.14
0.24 (1.34%)
At close: Apr 17, 2025, 3:59 PM
18.14
0.00%
After-hours: Apr 17, 2025, 04:07 PM EDT

ArriVent BioPharma Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
-20.63M -20.56M -21.87M -17.42M -21.19M -14.4M -21.57M -12.17M -10.44M -11.77M -7.35M -7.35M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
952K 866K 765K 625K 319K 217K 193K 166K 113K 113K 99K 99K
4.39M 2.52M 2.37M -1.46M 5.67M 972K 9.07M -4.5M -5.58M -466K -1.95M -1.95M
n/a n/a n/a 999K 24K 2.45M -3.5M 546K 94K 2.19M 293K 293K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
3.53M 3.35M 2.02M -1.84M 5.96M -1.26M 12.77M -4.88M -5.56M -466K -1.95M -1.95M
-16.15M -16.34M -19.09M -18.63M -14.91M -15.44M -8.61M -16.88M -15.89M -9.93M -8.91M -8.91M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-194.16M n/a n/a n/a n/a n/a -25M n/a n/a n/a n/a n/a
n/a n/a n/a n/a 25M n/a n/a n/a n/a n/a n/a n/a
1.7M n/a n/a n/a 25M n/a n/a n/a n/a n/a n/a n/a
-192.47M n/a n/a n/a 25M n/a -25M n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
55K 531K 44K 1K -1.06M -1.03M 4K 26K 15K n/a 30M 30M
55K 531K 363K 185.63M -1.06M -1.03M -20K 44.97M 109.72M n/a 30M 30M
-208.56M -15.81M -18.72M 167M 9.03M -16.48M -33.63M 28.09M 93.83M -9.93M 79.46M n/a
-16.15M -16.34M -19.09M -18.63M -14.91M -15.44M -8.61M -16.88M -15.89M -9.93M -8.91M -8.91M